Objective: The aim of this study was to compare health-related quality of life (QoL) and anxiety/depressive symptoms in healthy siblings of children with celiac disease (CD) with age- and gender-similar healthy siblings of children without chronic illness. Materials and Methods: This controlled cross-sectional study, conducted in a pediatric gastroenterology and child psychiatry setting at a tertiary-care hospital, enrolled healthy siblings aged 8–17 years into a CD-sibling group (n=70) and a control group (n=70). Sociodemographic data were collected using a standardized form, QoL was assessed using the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales, and psychiatric symptoms were assessed using the Revised Child Anxiety and Depression Scale (RCADS). Between-group comparisons and Spearman rank correlations were used, and predictors of total anxiety and psychosocial QoL were examined using univariable and multivariable linear regression. Results: Sociodemographic and familial characteristics were largely comparable between groups. Compared with controls, the CD-sibling group had higher total anxiety scores (p=0.007), whereas depressive symptoms were similar between groups (p=0.758). Psychosocial and total QoL were lower in the CD-sibling group (both p<0.001), while physical QoL did not differ between groups (p=0.201). In multivariable models within the CD-sibling group, longer time since diagnosis and maternal psychiatric disorder independently predicted higher anxiety and poorer psychosocial QoL, whereas a greater number of siblings predicted lower anxiety and better psychosocial QoL. Conclusion: Healthy siblings of children with CD experience increased anxiety and reduced psychosocial/total QoL, underscoring the importance of family-centered monitoring that includes sibling well-being and maternal mental health.
11 August 2026 in American Journal of Therapeutics
Aims: This study aimed to compare serum 25-hydroxyvitamin D [25(OH)D], vitamin B12, and folate concentrations between children with autism spectrum disorder (ASD) and typically developing controls, and to examine their relationship with autism symptom severity.Methods: This case-control study combined prospective clinical evaluation with retrospective retrieval of routine serum 25(OH)D, vitamin B12, and folate measurements from electronic medical records. The study included 140 children aged 2-8 years, comprising 70 children with ASD and 70 age- and gender-comparable typically developing controls, at a tertiary university hospital in Turkiye. ASD diagnosis was established according to DSM-5 criteria, and symptom severity was assessed using the Childhood Autism Rating Scale (CARS). Group comparisons, correlation analyses, and multivariable linear regression were performed.Results: Children with ASD had lower mean serum 25(OH)D concentrations than controls (mean difference: -3.43 ng/ml, 95% CI: -6.07 to -0.79; Cohen’s d=-0.43; p=0.011). Vitamin B12 and folate concentrations did not differ significantly between groups. The frequencies of vitamin D, vitamin B12, and folate deficiencies were also comparable between the ASD and control groups. Within the ASD group, none of the evaluated micronutrients differed by ASD severity or correlated with CARS scores. In the multivariable linear regression analysis, ASD group status and season of blood sampling remained independently associated with serum 25(OH)D concentrations after adjustment for age, gender, and body-mass index z-score.Conclusion: Children with ASD had lower mean serum 25(OH)D concentrations than typically developing controls, although vitamin D deficiency rates were comparable between the groups. This finding suggests that vitamin D status may warrant attention as a modifiable aspect of nutritional health in this population but should not be interpreted as an ASD-specific biomarker. Longitudinal and intervention-based studies are needed to clarify the directionality and clinical significance of this association and the potential benefit of supplementation in ASD.